Chemotherapy-Induced Peripheral Neuropathy Impacts Quality Of Life And Activities Of Daily Living Of Brazilian Multiple Myeloma Patients
CONCLUSION: MM patients showed a high frequency of CIPN, which affected ADL and impaired HRQoL. Early and accurate detection of CIPN and dose management in patients with thalidomide and bortezomib-based regimens should be performed to provide better treatment outcomes and avoid permanent disabilities.PMID:37592770 | DOI:10.2174/1574886318666230817162424
Source: Current Drug Safety - Category: Drugs & Pharmacology Authors: Paula Lana de Miranda Drummond Roberta M árcia Marques Dos Santos L ívia Pena Silveira J éssica Soares Malta Adriano Max Moreira Reis Naiane Lima Costa Roberta Oliveira de Paula E Silva Evandro Maranh ão Fagundes Cristiane Aparecida Menezes de P ádua Source Type: research
More News: Brain | Brazil Health | Chemotherapy | Dexamethasone | Disability | Drugs & Pharmacology | Education | Malta Health | Men | Myeloma | Neurology | Peripheral Neuropathy | Study | Universities & Medical Training | Velcade | Women